Company Filing History:
Years Active: 2017
Title: Arto D Krikorian: Innovator in Btk Inhibitor Compounds
Introduction
Arto D Krikorian is a notable inventor based in Astoria, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of Bruton's Tyrosine Kinase (Btk) inhibitors. With a total of 2 patents to his name, his work is pivotal in addressing Btk mediated disorders.
Latest Patents
Krikorian's latest patents focus on Btk inhibitors. The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I or pharmaceutically acceptable salts thereof. These compounds are essential for pharmaceutical compositions and their therapeutic applications. In particular, the invention relates to the use of Btk inhibitor compounds in the treatment of Btk mediated disorders.
Career Highlights
Arto D Krikorian is currently associated with Merck Sharp & Dohme Corporation, where he continues to innovate in the pharmaceutical sector. His expertise in Btk inhibitors has positioned him as a key player in the development of new therapeutic options.
Collaborations
Krikorian has worked alongside notable colleagues such as Jian Liu and Ronald M Kim. Their collaborative efforts contribute to the advancement of research in the field of Btk inhibitors.
Conclusion
Arto D Krikorian's work in developing Btk inhibitors showcases his commitment to advancing medical science. His contributions are vital for the treatment of Btk mediated disorders, making him a significant figure in the pharmaceutical industry.